A Phase 1, Open-Label Evaluation of the Pharmacokinetics And Safety of a Single Dose of Apraglutide in Subjects With Normal and Impaired Renal Function

被引：0
|
作者：
Greig, Gerard [1 ]
Cong, Danni [2 ]
Hurley, Niamh [1 ]
Michel, Eric [1 ]
Youssef, Nader [1 ]
机构：
[1] VectivBio, Basel, Switzerland
[2] ICON PRA Hlth Sci, Dublin, Ireland
来源：
TRANSPLANTATION | 2022年 / 106卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P7.10
引用
收藏
页码：S544 / S544
页数：1
相关论文
共 50 条
  • [1] PHARMACOKINETICS AND TOLERABILITY OF A SINGLE DOSE OF APRAGLUTIDE IN SUBJECTS WITH NORMAL AND IMPAIRED RENAL FUNCTION: A PHASE 1, OPEN-LABEL, NON-RANDOMIZED, PARALLELGROUP STUDY
    Greig, Gerard
    Hurley, Niamh
    Michel, Eric
    Youssef, Nader N.
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S654 - S654
  • [2] AN OPEN-LABEL STUDY TO DETERMINE THE SAFETY AND PHARMACOKINETICS OF AT1001 IN SUBJECTS WITH IMPAIRED RENAL FUNCTION AND HEALTHY SUBJECTS WITH NORMAL RENAL FUNCTION
    Johnson, F. K.
    Mudd, P. N., Jr.
    Sitaraman, S.
    Boudes, P.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S85 - S85
  • [3] An Open-Label Study to Determine the Pharmacokinetics and Safety of Migalastat HCl in Subjects With Impaired Renal Function and Healthy Subjects With Normal Renal Function
    Johnson, Franklin K.
    Mudd, Paul N., Jr.
    DiMino, Tara
    Vosk, Jennie
    Sitaraman, Sheela
    Boudes, Pol
    France, Nicholas
    Barlow, Carrolee
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2015, 4 (04): : 256 - 261
  • [4] A Single-Dose, Open-Label Study of the Pharmacokinetics, Safety, and Tolerability of Lisdexamfetamine Dimesylate in Individuals With Normal and Impaired Renal Function
    Ermer, James
    Corcoran, Mary
    Lasseter, Kenneth
    Marbury, Thomas
    Yan, Brian
    Martin, Patrick T.
    [J]. THERAPEUTIC DRUG MONITORING, 2016, 38 (04) : 546 - 555
  • [5] Pharmacokinetics of tamsulosin in subjects with normal and varying degrees of impaired renal function: an open-label single-dose and multiple-dose study
    Wolzt, M
    Fabrizii, V
    Dorner, GT
    Zanaschka, G
    Leufkens, P
    Krauwinkel, WJJ
    Eichler, HG
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (04) : 367 - 373
  • [6] Pharmacokinetics of tamsulosin in subjects with normal and varying degrees of impaired renal function: an open-label single-dose and multiple-dose study
    M. Wolzt
    V. Fabrizii
    G. T. Dorner
    G. Zanaschka
    P. Leufkens
    W. J. J. Krauwinkel
    H.-G. Eichler
    [J]. European Journal of Clinical Pharmacology, 1998, 54 : 367 - 373
  • [7] AN OPEN-LABEL, SINGLE-DOSE, PHASE 1 STUDY OF THE PHARMACOKINETICS AND SAFETY OF JZP-110 IN SUBJECTS WITH NORMAL OR IMPAIRED RENAL FUNCTION AND WITH END-STAGE RENAL DISEASE REQUIRING HEMODIALYSIS
    Zomorodi, K.
    Chen, D.
    Lee, L.
    Lasseter, K.
    Marbury, T.
    [J]. SLEEP, 2017, 40 : A382 - A382
  • [8] Pharmacokinetics and Safety of Aclidinium Bromide, a Muscarinic Antagonist, in Adults With Normal or Impaired Renal Function: A Phase I, Open-Label, Single-Dose Clinical Trial
    Schmid, Karin
    Pascual, Silvia
    Gil, Esther Garcia
    Ortiz, Stephan
    Jansat, Josep M.
    [J]. CLINICAL THERAPEUTICS, 2010, 32 (10) : 1798 - 1812
  • [9] Evaluation of the Pharmacokinetics and Safety of a Single Oral Dose of Fasiglifam in Subjects with Normal or Varying Degrees of Impaired Renal Function
    Mayer M.
    Nudurupati S.
    Peng X.
    Marcinak J.
    [J]. Drugs in R&D, 2014, 14 (4) : 273 - 282
  • [10] Pharmacokinetics of single dose cerivastatin in subjects with normal and impaired renal function
    Vormfelde, SV
    Gleiter, CH
    Freudenthaler, S
    Muck, W
    Schmage, N
    Kuhlmann, J
    GundertRemy, U
    [J]. ATHEROSCLEROSIS, 1997, 130 : 127 - 127
12345